Reaction Details Report a problem with these data
Target
Bombesin receptor subtype-3
Ligand
BDBM50313749
Substrate
n/a
Meas. Tech.
ChEMBL_614787 (CHEMBL1113306)
EC50
106±n/a nM
Citation
He, S; Dobbelaar, PH; Liu, J; Jian, T; Sebhat, IK; Lin, LS; Goodman, A; Guo, C; Guzzo, PR; Hadden, M; Henderson, AJ; Ruenz, M; Sargent, BJ; Yet, L; Kelly, TM; Palyha, O; Kan, Y; Pan, J; Chen, H; Marsh, DJ; Shearman, LP; Strack, AM; Metzger, JM; Feighner, SD; Tan, C; Howard, AD; Tamvakopoulos, C; Peng, Q; Guan, XM; Reitman, ML; Patchett, AA; Wyvratt, MJ; Nargund, RP Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists. Bioorg Med Chem Lett 20:1913-7 (2010) [PubMed] Article
More Info.:
Target
Name:
Bombesin receptor subtype-3
Synonyms:
BRS-3 | BRS3 | BRS3_HUMAN | Bombesin 3 | Bombesin like receptor 3
Type:
Enzyme Catalytic Domain
Mol. Mass.:
44424.45
Organism:
Homo sapiens (Human)
Description:
Bombesin 3 BRS3 HUMAN::P32247
Residue:
399
Sequence:
MAQRQPHSPNQTLISITNDTESSSSVVSNDNTNKGWSGDNSPGIEALCAIYITYAVIISVGILGNAILIKVFFKTKSMQTVPNIFITSLAFGDLLLLLTCVPVDATHYLAEGWLFGRIGCKVLSFIRLTSVGVSVFTLTILSADRYKAVVKPLERQPSNAILKTCVKAGCVWIVSMIFALPEAIFSNVYTFRDPNKNMTFESCTSYPVSKKLLQEIHSLLCFLVFYIIPLSIISVYYSLIARTLYKSTLNIPTEEQSHARKQIESRKRIARTVLVLVALFALCWLPNHLLYLYHSFTSQTYVDPSAMHFIFTIFSRVLAFSNSCVNPFALYWLSKSFQKHFKAQLFCCKAERPEPPVADTSLTTLAVMGTVPGTGSIQMSEISVTSFTGCSVKQAEDRF